Innovation
15 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,542 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 2 |
Social engagement
Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include Cowen, Andera Partners, Life Sciences Partners, Forbion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 39% |
| Private equity | 7 | 39% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 3 | 17% |
Recent activity
19 May 2026
Event
Financial Times Briefing: Scaling Competitive Biopharma in Europe
14 Apr 2026
Event
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2026
8 Jan 2026
Event
Annual J.P. Morgan Healthcare Conference